The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Medically reviewed by Suzanne Fisher, RD Hypoglycemia (low blood sugar) treatments will depend on the severity of symptoms ...

People with diabetes who take insulin should have a prescription for either injectable glucagon or inhaled glucagon. In the ...

of crystalline glucagon. ¶ The patients' symptoms and their response to glucagon were recorded. Data on the effect of glucagon in 27 spontaneous insulin reactions occurring in 11 of the 18 ...

By inhibiting DPP4, vildagliptin causes an increase in glucagon like peptide-1 (GLP-1 ... With the exception of inhaled insulin, none of the other recently approved diabetes medications are ...